(3R)-3-methyl-4-[4-(4-methylsulfonylpiperazin-1-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine
C21H27N7O3S — CID 118869234
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3R)-3-methyl-4-[4-(4-methylsulfonylpiperazin-1-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine
(3R)-3-methyl-4-[4-(4-methylsulfonylpiperazin-1-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine (PubChem CID 118869234) has the molecular formula C21H27N7O3S and a molecular weight of 457.56 g/mol. Its IUPAC name is (3R)-3-methyl-4-[4-(4-methylsulfonylpiperazin-1-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine.
Molecular Properties
| Compound Name | (3R)-3-methyl-4-[4-(4-methylsulfonylpiperazin-1-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine |
|---|---|
| PubChem CID | 118869234 |
| Molecular Formula | C21H27N7O3S |
| Molecular Weight | 457.56 g/mol |
| Exact Mass | 457.19 |
| IUPAC Name | (3R)-3-methyl-4-[4-(4-methylsulfonylpiperazin-1-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine |
| SMILES | C[C@@H]1COCCN1c1cc(N2CCN(S(C)(=O)=O)CC2)c2ccnc(-c3ccn[nH]3)c2n1 |
| InChI | InChI=1S/C21H27N7O3S/c1-15-14-31-12-11-28(15)19-13-18(26-7-9-27(10-8-26)32(2,29)30)16-3-5-22-21(20(16)24-19)17-4-6-23-25-17/h3-6,13,15H,7-12,14H2,1-2H3,(H,23,25)/t15-/m1/s1 |
| InChIKey | PCENXOZMURIZBY-OAHLLOKOSA-N |
| XLogP | 1.33 |
| TPSA | 107.55 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 457.56 |
| LogP ≤ 5 | 1.33 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118869234 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.